AMEX:ARMP
Armata Pharmaceuticals, Inc.
- Stock
Last Close
2.21
25/09 13:50
Market Cap
96.89M
Beta: 0.54
Volume Today
450
Avg: 13.05K
PE Ratio
−2.27
PFCF: −2.59
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -309.50K - | -309.50K 0% | -280.50K - | -1.77M 532.80% | -1.49M 15.80% | |||||||
average payables | 2.04M - | 1.07M 47.43% | 732K 31.81% | 1.56M 113.32% | 1.12M 28.37% | 653.50K 41.57% | 638K 2.37% | 751.50K 17.79% | 1.05M 39.32% | 1.41M 34.48% | 1.63M 15.87% | |
average receivables | 324.50K - | 54K 83.36% | 112.50K 108.33% | 384.50K 241.78% | 322K 16.25% | 280.50K - | 1.77M 532.80% | 2.46M 38.73% | 2.65M 7.59% | |||
book value per share | -983.68 - | 128.43 113.06% | 328.94 156.12% | 138.36 57.94% | 16.94 87.75% | 6.25 63.11% | 2.18 65.11% | 1.15 47.31% | 1.05 8.28% | 1.05 0.15% | -0.89 184.48% | |
capex per share | -7.06 - | -44.92 536.62% | -5.43 87.90% | -3.97 26.93% | -0.13 96.80% | -0.03 74.47% | -0.02 39.69% | -0.05 156.46% | -0.05 7.77% | -0.06 19.17% | -0.23 250.15% | |
capex to depreciation | -1.24 - | -7.61 511.59% | -0.64 91.64% | -0.76 18.82% | -0.16 79.49% | -0.11 27.06% | -0.10 14.27% | -0.74 662.83% | -1.12 50.81% | -2.48 122.21% | -8.38 238.02% | |
capex to operating cash flow | 0.01 - | 0.10 598.14% | 0.02 77.54% | 0.03 22.72% | 0.01 76.05% | 0.00 25.67% | 0.01 79.26% | 0.05 436.46% | 0.06 22.64% | 0.07 23.06% | 0.17 152.28% | |
capex to revenue | -0.31 - | -2.94 836.41% | -0.44 84.96% | -1.07 142.72% | -0.50 53.00% | -1.80 - | ||||||
cash per share | 1.41K - | 245.92 82.53% | 242.43 1.42% | 81.27 66.48% | 11.25 86.16% | 6.02 46.51% | 0.90 85.02% | 0.59 34.79% | 0.43 27.39% | 0.43 1.47% | 0.37 13.44% | |
days of inventory on hand | ||||||||||||
days payables outstanding | 595.19 - | |||||||||||
days sales outstanding | 8.98 - | 89.24 893.28% | 96.05 7.63% | 904.08 841.23% | 271.03 - | |||||||
debt to assets | 0.04 - | 0.11 - | 0.33 195.83% | 0.54 63.62% | 0.51 6.45% | 0.83 63.87% | ||||||
debt to equity | 0.08 - | 0.20 - | 0.70 255.45% | 1.50 114.50% | 1.35 9.55% | -2.86 311.58% | ||||||
dividend yield | 0.02 - | |||||||||||
earnings yield | -1.15 - | 0.60 152.13% | -0.02 103.98% | -4.35 18,062.49% | -1.99 54.27% | -3.09 55.41% | -0.87 71.72% | -0.47 46.76% | -0.18 62.25% | -0.87 393.48% | -0.59 31.90% | |
enterprise value | 30.24M - | 31.82M 5.21% | 12.17M 61.77% | -579.06K 104.76% | 1.32M 327.84% | -4.24M 421.47% | 18.58M 538.11% | 52.50M 182.53% | 159.79M 204.38% | 76.49M 52.13% | 223.73M 192.51% | |
enterprise value over ebitda | 1.18 - | -0.62 152.76% | -0.62 0.15% | 0.07 111.00% | -0.21 410.73% | 0.51 338.30% | -1.02 301.35% | -2.57 151.47% | -7.06 174.69% | -2.12 69.93% | -5.60 164.19% | |
ev to operating cash flow | -4.06 - | -2.53 37.67% | -1.24 50.86% | 0.05 104.40% | -0.14 362.47% | 0.45 414.96% | -1.19 363.79% | -2.87 140.97% | -6.78 135.88% | -2.35 65.26% | -4.72 100.34% | |
ev to sales | 93.06 - | 77.80 16.40% | 25.61 67.08% | -2.23 108.70% | 11.47 615.12% | 49.40 - | ||||||
free cash flow per share | -522.24 - | -514.70 1.44% | -258.49 49.78% | -154.65 40.17% | -20.27 86.89% | -6.95 65.71% | -2.35 66.23% | -1.16 50.46% | -1.03 11.27% | -1.01 1.99% | -1.54 52.26% | |
free cash flow yield | -0.15 - | -0.36 140.38% | -0.46 29.34% | -2.51 441.17% | -1.43 42.89% | -2.41 67.89% | -0.72 69.99% | -0.39 46.06% | -0.19 51.67% | -0.82 333.14% | -0.48 41.73% | |
graham net net | -2.20K - | -692.20 68.54% | -241.01 65.18% | -36.82 84.72% | 3.78 110.27% | 3.50 7.45% | -0.72 120.60% | -0.66 8.15% | -1.38 108.85% | -1.27 8.39% | -3.49 175.63% | |
graham number | 9.46K - | 1.58K 83.30% | 314.34 80.10% | 913.50 190.61% | 103.58 88.66% | 35.44 65.78% | 11.81 66.68% | 5.99 49.25% | 4.78 20.27% | 5.05 5.59% | 6.19 22.61% | |
income quality | 0.13 - | -0.54 526.66% | 18.96 3,584.26% | 0.56 97.03% | 0.72 27.38% | 0.77 8.20% | 0.80 3.25% | 0.82 2.97% | 1.02 23.61% | 0.88 13.58% | 0.69 21.94% | |
intangibles to total assets | 0.46 - | 0.71 56.48% | 0.65 9.27% | 0.59 8.40% | 0.44 25.10% | 0.25 43.52% | 0.54 115.73% | 0.35 35.59% | 0.20 43.36% | 0.14 27.20% | 0.03 77.87% | |
interest coverage | -5.23 - | -21.22 - | -34.37 62.02% | -372.22 982.84% | -1.27K 242.27% | -15.57 98.78% | ||||||
interest debt per share | 198.04 - | 11.43 - | 0.57 - | 0.84 48.06% | 1.58 88.08% | 1.42 9.78% | 2.62 83.75% | |||||
inventory turnover | ||||||||||||
invested capital | 0.08 - | 0.20 - | 0.70 255.45% | 1.50 114.50% | 1.35 9.55% | -2.86 311.58% | ||||||
market cap | 50.60M - | 38.40M 24.11% | 21.54M 43.92% | 4.33M 79.90% | 6.45M 49.03% | 3.92M 39.30% | 21.75M 455.48% | 49.00M 125.26% | 132.09M 169.59% | 42.52M 67.81% | 116.88M 174.86% | |
net current asset value | -31.63M - | -18.16M 42.59% | -8.76M 51.75% | -2.12M 75.84% | 1.98M 193.43% | 5.00M 152.53% | -4.20M 184.14% | -9.81M 133.48% | -29.38M 199.36% | -32.71M 11.34% | -122.88M 275.69% | |
net debt to ebitda | -0.79 - | 0.13 116.21% | 0.48 272.96% | 0.58 21.05% | 0.83 42.61% | 0.98 17.82% | 0.17 82.14% | -0.17 198.30% | -1.22 614.06% | -0.94 22.98% | -2.68 184.15% | |
net income per share | -4.04K - | 863.53 121.37% | -13.35 101.55% | -268.06 1,907.91% | -28.14 89.50% | -8.93 68.26% | -2.84 68.17% | -1.39 51.11% | -0.96 30.69% | -1.08 11.66% | -1.91 77.93% | |
operating cash flow per share | -515.18 - | -469.79 8.81% | -253.06 46.13% | -150.68 40.46% | -20.15 86.63% | -6.92 65.65% | -2.33 66.36% | -1.11 52.19% | -0.98 12.13% | -0.95 3.16% | -1.31 38.79% | |
payables turnover | 0.61 - | |||||||||||
receivables turnover | 40.63 - | 4.09 89.93% | 3.80 7.09% | 0.40 89.38% | 1.35 - | |||||||
research and ddevelopement to revenue | 20.01 - | 14.19 29.06% | 8.40 40.79% | 21.84 159.85% | 25.05 14.72% | 7.46 - | ||||||
return on tangible assets | -2.82 - | 2.80 199.29% | -0.05 101.65% | -2.54 5,379.36% | -2.07 18.38% | -1.36 34.36% | -1.63 19.60% | -0.89 45.53% | -0.41 53.19% | -0.45 8.42% | -0.65 44.31% | |
revenue per share | 22.48 - | 15.28 32.01% | 12.29 19.59% | 3.70 69.89% | 0.25 93.19% | 0.13 - | ||||||
roe | 4.11 - | 6.72 63.70% | -0.04 100.60% | -1.94 4,673.83% | -1.66 14.29% | -1.43 13.94% | -1.30 8.77% | -1.21 7.20% | -0.91 24.44% | -1.02 11.83% | 2.15 310.61% | |
roic | 1.84 - | -10.72 683.34% | -0.70 93.42% | -2.16 206.13% | -1.90 12.05% | -1.44 24.16% | -0.95 34.02% | -0.50 47.37% | -0.24 52.84% | -0.28 17.17% | -0.46 67.71% | |
sales general and administrative to revenue | 27.10 - | 16.75 38.21% | 13.52 19.29% | 32.36 139.37% | 66 103.97% | 2.57 - | ||||||
shareholders equity per share | -983.68 - | 128.43 113.06% | 328.94 156.12% | 138.36 57.94% | 16.94 87.75% | 6.25 63.11% | 2.18 65.11% | 1.15 47.31% | 1.05 8.28% | 1.05 0.15% | -0.89 184.48% | |
stock based compensation to revenue | 4.42 - | 4.73 7.06% | 1.02 78.52% | 7.67 654.60% | 6.09 20.67% | 0.21 - | ||||||
tangible asset value | -31.49M - | -16.94M 46.20% | -7.63M 54.95% | -1.04M 86.31% | 2.79M 367.37% | 5.50M 96.78% | 847K 84.59% | 5.11M 503.42% | 11.65M 127.96% | 22.33M 91.69% | -35.55M 259.20% | |
tangible book value per share | -2.18K - | -633.01 70.94% | -197.46 68.81% | -14.87 92.47% | 6.12 141.18% | 4.06 33.78% | 0.13 96.88% | 0.31 146.03% | 0.48 55.24% | 0.65 34.73% | -0.99 251.34% | |
working capital | 18.39M - | 5.15M 71.98% | 7.63M 48.12% | 2.77M 63.64% | 3.42M 23.14% | 5.84M 70.79% | 1.78M 69.57% | 4.14M 133.16% | 10.18M 145.86% | 2.17M 78.65% | 2.69M 23.74% |
All numbers in USD (except ratios and percentages)